¿Carcinoma de mama o carcinoma de glándula sudorípara? Presentación de dos casos y análisis de la literatura
Resumen
El carcinoma apocrino primario de glándula sudorípara es una neoplasia con una muy baja incidencia, que puede representar un reto diagnóstico, clínico e histológico, y un reto terapéutico local, adyuvante y de la enfermedad avanzada. La edad media de los pacientes es de alrededor de 67 años, y no se ha observado preferencia según el sexo. Se presenta con mayor frecuencia en las axilas y en el cuero cabelludo. Se caracteriza clínicamente por un lento crecimiento, aunque puede progresar agresivamente, con compromiso local, ganglionar y metastásico, principalmente, pulmonar, hepático y óseo. El tratamiento recomendado –una vez establecida la histología– consiste en una resección local amplia con un margen claro de 1 a 2 cm y linfadenectomía regional si se detectan ganglios clínicamente positivos. El tratamiento adyuvante (radioterapia o quimioterapia) y de la enfermedad avanzada no está claramente establecido.
Se presentan dos pacientes de sexo femenino con sospecha inicial de cáncer de mama, en quienes se diagnosticó finalmente un carcinoma apocrino de glándula sudorípara.
Descargas
Referencias bibliográficas
Gatti AP, Tonello L, Pfaffenzeller W, Savóia FO, Goergen DI, De Pieri Coan R, et al. Apocrine sweat gland adenocarcinoma: A rare case report and review. Int J Surg Case Rep. 2017;36:78-81. https://doi.org/10.1016/j.ijscr.2017.04.0
Jandali DB, Ganti A, Al-Khudari S, Tajudeen BA, Revenaugh PC. Prognostic factors and survival outcomes for head and neck cutaneous adnexal cancers. Am J Otolaryngol. 2019;40:110-14. https://doi.org/10.1016/j.amjoto.2018.09.011
Wauer U, Sellei R, Zoga E, Braun S, Lorenz D. Atypical course of an apocrine sweat gland carcinoma: A very rare malignant tumor and his interdisciplinary treatment. SM J Case Rep. 2017;3:1052.
Brenn T. Do not break a sweat: Avoiding pitfalls in the diagnosis of sweat gland tumors. Mod Pathol. 2019;33:25-41. https://doi.org/10.1038/s41379-019-0377-7
Ahn CS, Sangüeza OP. Malignant sweat gland tumors. Hematol Oncol Clin North Am. 2019;33:53-71. https://doi.org/10.1016/j.hoc.2018.09.002
Paties C, Taccagni GL, Papotti M, Valente G, Zangrandi A, Aloi F. Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer. 1993;71:375-81. https://doi.org/10.1002/1097-0142(19930115)71:2<375::aid-cncr2820710218>3.0.co;2-4
Le LP, Dias-Santagata D, Pawlak AC, Cosper AK, Nguyen AT, Selim MA, et al. Apocrineeccrine carcinomas: molecular and immunohistochemical analyses. PLoS ONE 2012;7:e47290. https://doi.org/10.1371/journal.pone.0047290
Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, et al. A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience. Breast J. 2018;24:1105-8. https://doi.org/10.1111/tbj.13140
Zembowicz A, García CF, Tannous ZS, Mihm MC, Koerner F, Pilch BZ. Endocrine mucinproducing sweat gland carcinoma. Am J Surg Pathol. 2005;29:1330-9. https://doi.org/10.1097/01.pas.0000170348.40057.60
Agni M, Raven ML, Bowen RC, Laver NV, Chevez-Barrios P, Milman T, et al. An update on endocrine mucin-producing sweat gland carcinoma. Am J Surg Pathol. 2020;44:1005-16. https://doi.org/10.1097/PAS.0000000000001462
Warkel RL. Apocrine gland adenoma and adenocarcinoma of the axilla. Arch Dermatol. 1978;114:198-203. https://doi.org/10.1001/archderm.1978.01640140016004
Kazakov DV, McKee PH, Michal M, Kacerovska D. Cutaneous adnexal tumors. First edition. Philadelphia: Lippincott Williams & Wilkins Health; 2012. p. 830.
Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumors. Fourth edition. Lyon: International Agency for Research on Cancer, World Health Organization, International Academy of Pathology; 2018. p. 470.
Suyama T, Yokoyama M, Nishimura T, Kobayashi K, Katagiri K. Sweat gland carcinoma of the left axilla with disseminated carcinomatosis of the bone marrow. Int J Dermatol. 2020;59:e281-4. https://doi.org/10.1111/ijd.14854
Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL. Cutaneous apocrine adenocarcinoma: Defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol. 2012;105:415-9. https://doi.org/10.1002/jso.22023
Al-Hakami H, Awad BI, Al-Garni M, Al-Maghrabi HA, Al-Shareef N. Apocrine carcinoma of the scalp with neck lymph node metastasis: A case report and review of the literature. J Family Med Prim Care. 2019;8:3758-62 https://doi.org/10.4103/jfmpc.jfmpc_833_19
Chamberlain RS, Huber K, White JC, Travaglino-Parda R. Apocrine gland carcinoma of the axilla: Review of the literature and recommendations for treatment. Am J Clin Oncol. 1999;22:131-5. https://doi.org/10.1097/00000421-199904000-00005
Seong MK, Kim EK, Han K, Seol H, Kim HA, Noh WC. Primary apocrine sweat gland carcinomas of the axilla: A report of two cases and a review of the literature. World J Surg Oncol. 2015;13:59. https://doi.org/10.1186/s12957-015-0473-1
Meattini I, Pezzulla D, Saieva C, Bernini M, Orzalesi L, Sánchez LJ, et al. Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: A case-control study. Clin Breast Cancer. 2018;18:e773-80. https://doi.org/10.1016/j.clbc.2018.02.012
Miller DH, Peterson JL, Buskirk SJ, Vallow LA, Ta R, Joseph R, et al. Management of metastatic apocrine hidradenocarcinoma with chemotherapy and radiation. Rare Tumors. 2015;7:13335. https://doi.org/10.4081/rt.2015.6082
Fujisawa Y, Fujimoto M. Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine. J Dermatol. 2014;41:280-2. https://doi.org/10.1111/1346-8138.12414
Goldstein R, Stefanato CM, Warbey V, Harries M. Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy. Future Oncol. 2012;8:1199-203. https://doi.org/10.2217/fon.12.94
Daniel SJ, Nader R, Kost K, Hüttner I. Facial sweat gland carcinoma metastasizing to neck nodes: A diagnostic and therapeutic challenge. Arch Otolaryngol Head Neck Surg. 2001;127:1495-8. https://doi.org/10.1001/archotol.127.12.1495
Hicham T, Mohammed B, Naoufa H. Primary cutaneous apocrine carcinoma with distant metastasis. J Cancer Clin Trials. 2018;3:2. https://doi.org/10.4172/2577-0535.1000145
